Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nolato ABCHIX:NOLABS 75 Market Cap is kr13,927 Mil as of Aug. 25, 2026. GuruFocus rates CHIX:NOLABS with a GF Score™ of 75/100 and a GF Value™ of kr51.16. The stock has 2 warning signs investors should review. Among 861 Medical Devices & Instruments companies, Nolato AB ranks better than 83.74% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nolato AB's share price for the quarter that ended in Jun. 2026 was kr48.875. Nolato AB's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 269 Mil. Therefore, Nolato AB's market cap for the quarter that ended in Jun. 2026 was kr13,166 Mil.
Nolato AB's quarterly market cap
declined
from Dec. 2025 (kr16,829 Mil) to Mar. 2026 (kr13,927 Mil) and
declined
from Mar. 2026 (kr13,927 Mil) to Jun. 2026 (kr13,166 Mil).
Nolato AB's annual market cap
stayed the same
from Dec. 2023 (kr13,752 Mil) to Dec. 2024 (kr13,752 Mil) but then
increased
from Dec. 2024 (kr13,752 Mil) to Dec. 2025 (kr16,829 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nolato AB's Enterprise Value for Today is kr14,899 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nolato AB Market Cap Related Terms
Nolato AB Market Cap Historical Data
* Premium members only.
The historical data trend for Nolato AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:NOLABS vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, Nolato AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Nolato AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nolato AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nolato AB (CHIX:NOLABS) has a Market Cap of kr13,927 Mil as of Aug. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nolato AB and its competitors. According to the industry distribution chart, Nolato AB ranks #140 out of 861 companies in the Medical Devices & Instruments industry, placing it in the top 16.3%.
Is Nolato AB's Market Cap too high?
Nolato AB's current Market Cap is kr13,927 Mil. Based on the distribution chart, Nolato AB ranks #140 out of 861 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nolato AB has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #140 out of 861 companies for Market Cap. This places Nolato AB in the top 16% of its industry — outperforming the majority of peers. The industry median Market Cap is 122.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.52, based on 861 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nolato AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nolato AB's current Market Cap is kr13,927 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Nolato AB (CHIX:NOLABS) has a current Market Cap of kr13,927 Mil. The stock's GF Value™ is kr51.16, compared to a current price of kr48.88 — trading 4.5% below its estimated fair value. The current Market Cap is kr13,927 Mil. Nolato AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nolato AB (CHIX:NOLABS), the current Market Cap is kr13,927 Mil as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (CHIX:NOLABS) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of kr48.88 is trading 4.5% below its estimated GF Value™ of kr51.16.
Key valuation signals for CHIX:NOLABS:
Market Cap: kr13,927 Mil
GF Value™: kr51.16 vs. price of kr48.88 (4.5% below fair value)
No single metric tells the full story. See the CHIX:NOLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
75GF Score
Get the complete analysis for CHIX:NOLABS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:NOLABS has been successfully added to your 
